Streetbeat News

Earnings

PTMN

Portman Ridge Finance (NASDAQ:PTMN) is scheduled to release its quarterly earnings report on March 13, 2024, with an estimated EPS of $0.79. Analysts and investors will be closely watching for not only an earnings beat but also positive guidance for future growth. The company's past earnings performance shows a mixed record of beating and missing EPS estimates, with corresponding stock price movements. Currently, PTMN shares are trading at $19.034, reflecting a 10.28% decline over the last 52 weeks, indicating potential concern among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 4:01 pm

GWH

ESS Tech (NYSE:GWH) is scheduled to release its quarterly earnings report on March 13, 2024, with an expected EPS of $-0.11. Analysts and investors will be closely watching for not only an earnings beat but also positive future guidance. Historical data shows mixed reactions to past earnings, with share prices fluctuating post-announcement. Currently, shares are trading at $0.8508, marking a 21.49% decline over the last year, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 4:00 pm

ARM

The analysis of ARM Holdings in the Semiconductors & Semiconductor Equipment industry reveals it is priced at a premium with high PE, PB, and PS ratios compared to industry averages, indicating potential overvaluation. Despite this, ARM's remarkable revenue growth outperforms the industry average. However, its lower ROE, EBITDA, and gross profit suggest weaker profitability and operational performance. ARM's lower debt-to-equity ratio indicates a stronger financial position with less reliance on debt financing.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 4:00 pm

INCY

In the past three months, 8 analysts have provided diverse ratings for Incyte (NASDAQ:INCY), with a mix of bullish and indifferent perspectives. The average 12-month price target is $73.12, slightly down from the previous $73.83. Analysts' actions include maintaining, raising, and lowering ratings and price targets, reflecting their response to Incyte's market performance and developments. Incyte's financial performance shows a revenue growth of 9.35% but below industry benchmarks in net margin, ROE, and ROA, indicating challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 4:00 pm

VRA

Vera Bradley (NASDAQ:VRA) is scheduled to release its quarterly earnings report on March 13, 2024, with analysts expecting an EPS of $0.14. The company's past earnings performance shows a history of beating EPS estimates, which has occasionally led to positive stock price movements. Shares of Vera Bradley have increased by 25.44% over the last 52 weeks, indicating a generally positive outlook from long-term shareholders. Investors will be particularly attentive to the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 4:00 pm

CHRS

Coherus BioSciences (NASDAQ:CHRS) is scheduled to release its quarterly earnings report on March 13, 2024, with an expected EPS of $-0.12. Historical data shows mixed reactions to past earnings, with significant price changes following the announcements. Shares have declined 63.34% over the last year, indicating investor concern ahead of this release.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 4:00 pm

AMD

The analysis of Advanced Micro Devices (AMD) against its competitors in the Semiconductors & Semiconductor Equipment industry reveals AMD's premium valuation with a high PE ratio, potential undervaluation based on PB ratio, and challenges in profitability and growth. AMD's acquisition of Xilinx aims to diversify its business and enhance opportunities in key markets. The company's financial health is indicated by a lower debt-to-equity ratio compared to its top 4 peers, suggesting less reliance on debt financing.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 4:00 pm

AAPL

This article provides an in-depth analysis of Apple Inc. (AAPL) within the Technology Hardware, Storage & Peripherals industry, comparing it with competitors on key financial metrics. Apple shows potential for growth with a lower PE ratio than the industry average, trades at a premium based on its PB and PS ratios, and demonstrates strong profitability with high ROE, EBITDA, and gross profit. However, its revenue growth is below the industry average, indicating potential challenges in sales volume increase.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 4:00 pm

RERE

ATRenew Inc. (NYSE:RERE) shares rose after reporting a 300% increase in quarterly earnings per share and a 26.23% increase in sales year-over-year. The company also announced a $20 million share repurchase program and provided a positive revenue outlook for Q1 2024, expecting a 23.6% to 27.1% increase year-over-year. Despite a 54.52% decrease over the past year, the stock has gained 28.18% in the last month.

Portfolio Pulse from Erica Kollmann

March 12, 2024 | 3:57 pm

LULU

Investors have shown a bearish stance on Lululemon Athletica (NASDAQ:LULU), with options trading indicating a sentiment split of 38% bullish and 61% bearish. The options market dynamics reveal significant activity, including 13 uncommon trades, with puts totaling $328,019 and calls at $322,980. The price target window observed ranges from $420.0 to $495.0. LULU's current trading volume is 219,586, with a slight price decrease of -0.01%, positioned at $457.7. An earnings announcement is expected in 9 days, and an analyst from Needham has revised its rating to Buy with a price target of $525.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 3:31 pm